Discontinuation report APO-TERAZOSIN
Report ID | 4749 |
Drug Identification Number | 02234504 |
Brand name | APO-TERAZOSIN |
Common or Proper name | TERAZOSIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TERAZOSIN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-05-31 |
Actual discontinuation date | 2017-10-31 |
Remaining supply date | 2016-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | APO-TERAZOSIN 5 MG TAB 100 BTL is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-02-05 | French | Compare |
v3 | 2018-02-05 | English | Compare |
v2 | 2017-03-30 | French | Compare |
v1 | 2017-03-30 | English | Compare |
Showing 1 to 4 of 4